Year: 2011
Type: article
Abstract: There many open questions concerning the concept of primary prevention in FM. Diagnostic or classification criteria are not universally accepted, and this leads to difficulties in establishing the onset and duration of the disease. In the case of FM, primary prevention may consist of the immediate care of acute pain or treatment for affective disturbances as we do not have any specific laboratory or instrumental tests to determine risk factors of the disease. The goal of secondary prevention is early detection of the disease when patients are largely asymptomatic and intervention improves outcome. Screening allows for identification of an unrecognized disease or risk factor, which, for potential FM patients, includes analysis of tender points, Fibromyalgia Impact Questionnaire (FIQ), pain location and intensity, and fatigue and sleep complaints. Tertiary prevention inhibits further deterioration or reduces complications after the disease has developed. In FM the aim of treatment is to decrease pain and increase function via multimodal therapeutic strategies, which, in most cases, includes pharmacological and non-pharmacological interventions. Patients with FM are high consumers of health care services, and FM is associated with significant productivity-related costs. The degree of disability and the number of comorbidities are strongly associated with costs. An earlier diagnosis of FM can reduce referral costs and investigations, thus, leading to a net savings for the health care sector. However, every social assessment is closely related to the socio-economic level of the general population and to the legislation of the country in which the FM patient resides.
Source: Reumatismo
Authors: L. Altomonte, F. Atzeni, G. Leardini, A. Marsico, R. Gorla, R. Casale, G. Cassisi, S. Stisi, F. Salaffi, F. Marinangeli, M.A. Giamberardino, M. Di Franco, G. Biasi, G. Arioli, A. Alciati, F. Ceccherelli, L. Bazzichi, R. Carignola, M. Cazzola, R. Torta, D. Buskila, M. Spath, R.H. Gracely, P. Sarzi-Puttini
Institutions: St. Eugenio Hospital, Luigi Sacco Hospital, IRCCS Ospedale Galeazzi - Sant'Ambrogio, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, University of Brescia, Istituti Clinici Scientifici Maugeri, Fondazione Salvatore Maugeri, Azienda Ospedaliera G.Rummo, Marche Polytechnic University, University of L'Aquila, University of Chieti-Pescara, Sapienza University of Rome, University of Siena, University of Padua, Istituto Oncologico Veneto, University of Pisa, University of Turin, Ospedale di Circolo e Fondazione Macchi, Ben-Gurion University of the Negev, Soroka Medical Center, Ludwig-Maximilians-Universität München, University of Michigan, Michigan Medicine
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W1984195538